AmeriFlex Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$335	Sell	62 -2,000	-97%	-$10.8K	﹤0.01%	1030
2025 Q1	$10.9K	Buy	2,062 +2,000	+3,226%	+$10.6K	﹤0.01%	827
2024 Q4	$449	Buy	+62	New	+$449	﹤0.01%	1127